0001209191-22-037521.txt : 20220616
0001209191-22-037521.hdr.sgml : 20220616
20220616171219
ACCESSION NUMBER: 0001209191-22-037521
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20220615
FILED AS OF DATE: 20220616
DATE AS OF CHANGE: 20220616
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Makara Richard
CENTRAL INDEX KEY: 0001798130
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36279
FILM NUMBER: 221021444
MAIL ADDRESS:
STREET 1: C/O CARA THERAPEUTICS, INC.
STREET 2: 4 STAMFORD PLAZA, 107 ELM STREET, 9TH FL
CITY: STAMDFORD
STATE: CT
ZIP: 06902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cara Therapeutics, Inc.
CENTRAL INDEX KEY: 0001346830
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4 STAMFORD PLAZA
STREET 2: 107 ELM STREET 9TH FLOOR
CITY: STAMFORD
STATE: CT
ZIP: 06902
BUSINESS PHONE: 203-406-3700
MAIL ADDRESS:
STREET 1: 4 STAMFORD PLAZA
STREET 2: 107 ELM STREET 9TH FLOOR
CITY: STAMFORD
STATE: CT
ZIP: 06902
FORMER COMPANY:
FORMER CONFORMED NAME: Cara Therapeutics Inc
DATE OF NAME CHANGE: 20051213
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2022-06-15
0
0001346830
Cara Therapeutics, Inc.
CARA
0001798130
Makara Richard
C/O CARA THERAPEUTICS, INC.
107 ELM STREET, 4 STAMFORD PLAZA
STAMFORD
CT
06902
0
1
0
0
VP, Head of Accting;Controller
Common Stock
6083
D
Stock Option (Right to Buy)
17.41
2027-03-08
Common Stock
20000
D
Stock Option (Right to Buy)
13.51
2027-08-17
Common Stock
20000
D
Stock Option (Right to Buy)
14.18
2028-03-06
Common Stock
20000
D
Stock Option (Right to Buy)
16.10
2029-03-06
Common Stock
30000
D
Stock Option (Right to Buy)
16.36
2030-02-24
Common Stock
30000
D
Stock Option (Right to Buy)
18.93
2031-03-03
Common Stock
30000
D
Stock Option (Right to Buy)
10.46
2032-02-25
Common Stock
20000
D
Includes 5,083 shares underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. (1) 50% of the RSUs will vest on December 15, 2022; and (2) the remaining 50% of the RSUs will vest on June 15,2023, subject to the Reporting Person's continued service to the Issuer on each such date.
Fully vested and immediately exercisable.
The option vests and becomes exercisable in a series of 48 successive equal monthly installments beginning on April 6, 2019, subject to the Reporting Person's continuous service with the Issuer as of each such date.
The option vests and becomes exercisable in a series of 48 successive equal monthly installments beginning on March 24, 2020, subject to the Reporting Person's continuous service with the Issuer as of each such date.
The option vests and becomes exercisable in a series of 48 successive equal monthly installments beginning on April 3, 2021, subject to the Reporting Person's continuous service with the Issuer as of each such date.
The option vests and becomes exercisable in a series of 48 successive equal monthly installments beginning on March 25, 2022, subject to the Reporting Person's continuous service with the Issuer as of each such date.
Exhibit List - Exhibit 24 - Power of Attorney
/s/ Darren DeStefano, Attorney-in-Fact
2022-06-16
EX-24
2
poa.txt
POA DOCUMENT
POWER OF ATTORNEY
(For Executing Form ID and Forms 3, 4 and 5)
Know all by these presents that the undersigned hereby constitutes and appoints
each of Darren DeStefano, Jenny Park O'Shanick, Tommi McCarthy and Jordan B.
Verrilli of Cooley LLP and Christopher Posner and Scott Terrillion of Cara
Therapeutics, Inc., signing individually, the undersigned's true and lawful
attorney-in-fact and agents to:
(1) Prepare, execute in the undersigned's name and on the undersigned's behalf,
and submit to the Securities and Exchange Commission a Form ID, including
amendments thereto, and any other documents necessary or appropriate to obtain
codes and passwords enabling the undersigned to make electronic filings with the
Securities and Exchange Commission of reports required by Section 16(a) of the
Securities Exchange Act of 1934 or any rule or regulation thereunder;
(2) Prepare, execute in the undersigned's name and on the undersigned's behalf,
and submit to the Securities and Exchange Commission Forms 3, 4 and 5 (including
amendments thereto and joint filing agreements in connection therewith) in
accordance with Section 16(a) of the Securities Exchange Act of 1934 and the
rules thereunder;
(3) Do and perform any and all acts for and on behalf of the undersigned that
may be necessary or desirable to prepare and execute any such Form 3, 4 or 5
(including amendments thereto and joint filing agreements in connection
therewith) and file such forms with the Securities and Exchange Commission and
any stock exchange, self-regulatory association or any other authority; and
(4) Take any other action of any type whatsoever in connection with the
foregoing that, in the opinion of such attorney-in-fact, may be of benefit to,
in the best interest of, or legally required of the undersigned, it being
understood that the documents executed by the attorney-in-fact on behalf of the
undersigned pursuant to this Power of Attorney shall be in such form and shall
contain such terms and conditions as the attorney-in-fact may approve in the
attorney-in-fact's discretion.
The undersigned hereby grants to each such attorney-in-fact full power and
authority to do and perform any and every act and thing whatsoever requisite,
necessary, or proper to be done in the exercise of any of the rights and powers
herein granted, as fully to all intents and purposes as the undersigned might or
could do if personally present, with full power of substitution or revocation,
hereby ratifying and confirming all that such attorney-in-fact, or such
attorney-in- fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this Power of Attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, and
their substitutes, in serving in such capacity at the request of the
undersigned, are not assuming (nor is Cara Therapeutics, Inc. assuming) any of
the undersigned's responsibilities to comply with Section 16 of the Securities
Exchange Act of 1934.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by Cara
Therapeutics, Inc., unless earlier revoked by the undersigned in a signed
writing delivered to Cara Therapeutics, Inc. and the attorneys-in-fact. This
Power of Attorney revokes any other power of attorney that the undersigned has
previously granted to representatives of the Cara Therapeutics, Inc. and Cooley
LLP.
IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of the date written below.
Dated: June 7, 2022
By: /s/ Richard Makara
Name: Richard Makara